৳ ০.০০
আপনার সব স্বাস্থ্যসেবার সমাধান — এখন এক জায়গাতেই
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬
৳ ০.০০
১০৬৫৭
info@shukhee.com
টেলিকম ভবন, ৫৩/১, বক্স নগর, ঢাকা-১২১৬


Quantity:
Products
Payment
Delivery
Wikijet (Tirzepatide) Therapeutic Class: Dual GIP and GLP‑1 Receptor Agonist
Indications Wikijet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Limitations of Use
Not studied in patients with a history of pancreatitis.
Not indicated for use in patients with type 1 diabetes mellitus.
Pharmacology Tirzepatide is a 39‑amino‑acid modified peptide with a C20 fatty diacid moiety that binds albumin and prolongs half‑life. It selectively activates both GIP and GLP‑1 receptors, enhancing insulin secretion and reducing glucagon levels in a glucose‑dependent manner.
Dosage & Administration
Route: Subcutaneous injection.
Starting dose: 2.5 mg once weekly (for initiation, not glycemic control).
After 4 weeks: Increase to 5 mg once weekly.
Further titration: Increase by 2.5 mg increments after ≥4 weeks, up to a maximum of 15 mg once weekly.
Missed dose: Administer within 4 days; if >4 days, skip and resume on next scheduled day.
Injection sites: Abdomen, thigh, or upper arm. Rotate sites. Do not mix with insulin; administer separately.
Interactions
May increase risk of hypoglycemia with insulin or sulfonylureas → dose reduction may be needed.
Delays gastric emptying → may affect absorption of oral drugs with narrow therapeutic index (e.g., warfarin).
Oral contraceptives: Use non‑oral or barrier method for 4 weeks after initiation and after each dose escalation.
Contraindications
Hypersensitivity to tirzepatide or any component.
Personal/family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Side Effects Common: Nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, abdominal pain.
Pregnancy & Lactation Use only if potential benefit outweighs risk. Consider maternal glycemic control, breastfeeding benefits, and possible adverse effects on infant.
Precautions & Warnings
Counsel patients on thyroid tumor risk.
Monitor for pancreatitis; discontinue if suspected.
Reduce insulin/secretagogue dose to lower hypoglycemia risk.
Monitor renal function in patients with severe GI reactions.
Monitor diabetic retinopathy progression.
Evaluate gallbladder if cholelithiasis suspected.


Tirzepatide is an injectable medication used for type 2 diabetes management and, in many cases, weight management. It works as a dual agonist of GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, helping regulate blood sugar and appetite.
Tirzepatide helps lower blood glucose levels, improve insulin sensitivity, reduce appetite, and support significant weight loss. It may also reduce cardiovascular risk factors in patients with type 2 diabetes.





